Galanin
galanin | |
---|---|
Identifiers | |
Symbol | GAL |
Alt. symbols | GALN |
Entrez | 51083 |
HUGO | 4114 |
OMIM | 137035 |
RefSeq | NM_015973 |
UniProt | P22466 |
Other data | |
Locus | Chr. 11 q13.3-13.5 |
WikiDoc Resources for Galanin |
Articles |
---|
Most recent articles on Galanin |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Galanin at Clinical Trials.gov Clinical Trials on Galanin at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Galanin
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Directions to Hospitals Treating Galanin Risk calculators and risk factors for Galanin
|
Healthcare Provider Resources |
Causes & Risk Factors for Galanin |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Galanin is a 30 amino acid neuropeptide which is cleaved from preprogalanin. It is involved in a number of physiological processes such as regulation of food intake, metabolism and reproduction, regulation of neurotransmitter and hormone release, nociception, intestinal contraction and secretion, and more recently in nervous system development and response to injury. This wide diversity of action is mediated by several galanin receptor subtypes.
Galanin is predominantly an inhibitory, hyperpolarizing neuropeptide and as such inhibits neurotransmitter release. The Galanin receptor is often co-localized with classical neurotransmitters such as acetylcholine, dopamine, serotonin and norepinephrine and also with other neuromodulators such as Neuropeptide Y, Substance P and Vasoactive Intestinal Peptide.
Galanin has been implicated in the progression of Alzheimer's disease.
See also
External links
- Galanin at the US National Library of Medicine Medical Subject Headings (MeSH)